|2013||The journal releases the inaugural issue and is published as a quarterly journal under the direction of the founding Editor-in-Chief, Prof. Dr. Kenneth Cornetta.|
|2015||Biomedicines establishes the following section:
Tumor Immunology and Immunotherapy (later was renamed as Immunology and Immunotherapy).
|2016||Biomedicines is covered by Emerging Sources Citation Index (ESCI) of the Web of Science.
Biomedicines establishes the following section:
Neurologic Disease (later was renamed as Neurobiology and Neurologic Disease).
|2017||Biomedicines is covered by two important databases: PubMed and Scopus.
Biomedicines starts the Travel Awards project.
|2018||Biomedicines establishes the following section:
Natural compounds in Biomedicine (later was renamed as Drug Discovery and Development).
|2019||Biomedicines is covered by the Science Citation Index Expanded (SCIE).
Biomedicines establishes the following 7 sections:
Cancer Therapeutics (later was renamed as Cancer Biology and Therapeutics)
Nanotechnology and Biotechnology (later was renamed as Biomedical Materials and Nanomedicine)
Therapeutic Strategies in Different Diseases (later was renamed as Molecular and Translational Medicine)
Gene and Cell Therapy
Thrombosis and Hemostasis (discontinued later)
Model Systems in Research and Development (discontinued later)
Virology, Vaccines and Viral Vectors (discontinued later)
Tumor Cell Biology (discontinued later).
|2020||Biomedicines adopts a monthly publication schedule.
Biomedicines receives its first impact factor: 4.717. The journal ranks 30th out of 138 (Q1) titles in the 'Medicine, Research & Experimental' category, as well as 36th out of 270 (Q1) titles in 'Pharmacology & Pharmacy'.
Biomedicines publishes its 1,000th paper.
Biomedicines rearranges the sections as following:
Immunology and Immunotherapy
Neurobiology and Neurologic Disease
Drug Discovery and Development
Cancer Biology and Therapeutics
Gene and Cell Therapy
Molecular and Translational Medicine
Biomedical Materials and Nanomedicine.
|2021||Biomedicines starts the Young Investigator Award project.
Biomedicines organized the 1st International Electronic Conference on Biomedicine (ECB 2021).
Biomedicines organized the First Canadian Peptide and Protein Community Virtual Symposium (CPPC 2021).
Biomedicines received its 2020 impact factor (6.081).
|2013–2016||Founding Editor-in-Chief: Prof. Dr. Kenneth Cornetta|
|2016–present||Editor-in-Chief: Prof. Dr. Shaker A. Mousa|
|2016–2022||Section Editor-in-Chief: Dr. Vincenzo Cerullo for the Section on Tumor Immunology and Immunotherapy
|2016–present||Section Editor-in-Chief: Dr. Bruno Meloni for the Section on Neurologic Disease|
|2019–present||Section Editor-in-Chief: Prof. Dr. Jun Lu for the Section on Drug Discovery and Development
Section Editor-in-Chief: Dr. Veronique Baud for the Section on Cancer Therapeutics
Section Editor-in-Chief: Prof. Dr. Paul Rösch for the Section on Cell Biology and Pathology